Agilent Technologies Inc (A)vsFomento Economico Mexicano (FMX)
A
Agilent Technologies Inc
$115.62
-2.55%
HEALTHCARE · Cap: $33.53B
FMX
Fomento Economico Mexicano
$121.20
+1.08%
CONSUMER DEFENSIVE · Cap: $40.85B
Smart Verdict
WallStSmart Research — data-driven comparison
Fomento Economico Mexicano generates 11972% more annual revenue ($852.92B vs $7.07B). A leads profitability with a 18.3% profit margin vs 3.3%. A appears more attractively valued with a PEG of 1.23. A earns a higher WallStSmart Score of 61/100 (C+).
A
Buy61
out of 100
Grade: C+
FMX
Buy54
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-45.8%
Fair Value
$88.39
Current Price
$115.62
$27.23 premium
Intrinsic value data unavailable for FMX.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 20 in profit
Strong operational efficiency at 22.9%
Earnings expanding 167.8% YoY
Reasonable price relative to book value
Areas to Watch
Moderate valuation
Grey zone — moderate risk
Weak financial health signals
Earnings declined 3.6%
Moderate valuation
3.3% margin — thin
Weak financial health signals
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : A
The strongest argument for A centers on Return on Equity, Operating Margin. Profitability is solid with margins at 18.3% and operating margin at 22.9%. PEG of 1.23 suggests the stock is reasonably priced for its growth.
Bull Case : FMX
The strongest argument for FMX centers on EPS Growth, Price/Book.
Bear Case : A
The primary concerns for A are P/E Ratio, Altman Z-Score, Piotroski F-Score.
Bear Case : FMX
The primary concerns for FMX are P/E Ratio, Profit Margin, Piotroski F-Score. Thin 3.3% margins leave little buffer for downturns.
Key Dynamics to Monitor
A profiles as a mature stock while FMX is a value play — different risk/reward profiles.
A carries more volatility with a beta of 1.22 — expect wider price swings.
A is growing revenue faster at 7.0% — sustainability is the question.
FMX generates stronger free cash flow (842M), providing more financial flexibility.
Bottom Line
A scores higher overall (61/100 vs 54/100), backed by strong 18.3% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agilent Technologies Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.
Fomento Economico Mexicano
CONSUMER DEFENSIVE · BEVERAGES - BREWERS · USA
Fomento Econmico Mexicano, SAB de CV, is a bottler of Coca-Cola brand beverages. The company is headquartered in Monterrey, Mexico.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?